In 1951, a young African American mother named Henrietta
Lacks unknowingly became the source of one of the most significant
breakthroughs in medical science. At just 30 years old, Henrietta visited Johns
Hopkins Hospital—one of the few hospitals at the time that treated Black
patients—for help with an aggressive form of cervical cancer. During her
treatment, doctors removed a small sample of her tumor and passed it along to Dr.
George Gey, the head of the hospital’s tissue culture lab.
Back then, informed consent wasn’t a legal or ethical
requirement, and Henrietta was never told that her cells had been taken—or
that they would live on long after her death.
The Birth of the First Immortal Human
Cell Line
Unlike normal human cells, which typically stop dividing
after about 20 to 50 cycles, Henrietta’s cells—now known as HeLa cells—did
something extraordinary. They kept dividing. Not just for days or weeks,
but indefinitely.
This discovery stunned the scientific community. HeLa cells
became the first immortal human cell line, meaning they could be grown
endlessly in laboratories under the right conditions. Researchers around the
world quickly recognized their value, and the cells were soon mass-produced and
shipped globally for scientific study.
In fact, HeLa cells played a key role in some of the most
important medical advances of the 20th century, including:
- Jonas
Salk’s development of the polio vaccine (1954)
- Breakthroughs
in cancer research and tumor biology
- The
development of anticancer drugs
- Studies
related to AIDS, genetic mapping, and cell biology
Despite their widespread use, Henrietta’s name—and her
story—remained largely unknown for decades.
A Family in the Dark
Henrietta Lacks passed away just eight months after her
diagnosis, in October 1951, as the cancer spread rapidly throughout her body.
That very day, Dr. Gey appeared on television, holding a vial of HeLa cells and
proclaiming their potential to help cure cancer—without ever mentioning the
woman behind them.
It wasn’t until 25 years later that the Lacks family
learned that Henrietta’s cells had not only survived but had been shared,
studied, and even sold worldwide—without their knowledge, consent, or
compensation.
Despite the enormous contributions of HeLa cells to science
and medicine, neither Henrietta nor her family received any formal recognition
or financial benefit for decades.
The Story Finally Told
Though a few newspaper stories surfaced over the years, it
wasn’t until 2010 that the full story of Henrietta Lacks reached a broad
audience. That year, science journalist Rebecca Skloot published The
Immortal Life of Henrietta Lacks, a best-selling book that brought
international attention to the ethical issues surrounding the use of HeLa
cells. The book spent over two years on the New York Times Best Seller List
and sparked global conversations about ethics in biomedical research, informed
consent, and racial inequality in medicine.
Continuing Controversy and Ethical
Progress
In March 2013, German scientists published the entire
genome of HeLa cells—again without the Lacks family’s consent. The move
reignited public concern about the ongoing lack of oversight and respect for
Henrietta’s legacy.
Later that year, the U.S. National Institutes of Health
(NIH) reached an agreement with the Lacks family. The deal gave the family limited
control over who could access HeLa cell genetic data, marking a small but
significant step toward ethical transparency. However, even now, no
financial compensation has been granted to the Lacks family, despite the
billions of dollars’ worth of research and industry fueled by HeLa cells.
The Human Face Behind a Scientific
Revolution
Henrietta Lacks was not a scientist, nor did she ever
imagine that her cells would revolutionize medicine. But her legacy lives on in
every vaccine, every cancer treatment, and every cell biology breakthrough made
possible by HeLa cells.
Her story is a powerful reminder that behind every
scientific discovery is a human being—whose rights, dignity, and story deserve
to be honored.
 |
| A culture of HeLa cells, originally obtained from human cervical cancer cells. This line of cells has been dividing since 1951 and is now the most commonly used cell line in biological and drug research. |
No comments:
Post a Comment